Platelet-to-lymphocyte ratio acts as an independent risk factor for patients with hepatitis B virus-related hepatocellular carcinoma who received transarterial chemoembolization.

Tian, X-C; Liu, X-L; Zeng, F-R; Chen, Z; Wu, D-H

Tian, X-C; Liu, X-L; Zeng, F-R; Chen, Z; Wu, D-H.

Afiliación

Tian XC; Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, P.R. China. wudehua.gd@gmail.com.

Eur Rev Med Pharmacol Sci ; 20(11): 2302-9, 2016 06.

Article en En | MEDLINE | ID: mdl-27338055

Asunto(s)

Carcinoma Hepatocelular; Virus de la Hepatitis B; Neoplasias Hepáticas; Plaquetas; Quimioembolización Terapéutica; Humanos; Linfocitos; Pronóstico; Factores de Riesgo

Buscar en Google

Imprimir

XML

PubMed Links

Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Virus de la Hepatitis B / Carcinoma Hepatocelular / Neoplasias Hepáticas Tipo de estudio: Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Eur Rev Med Pharmacol Sci Asunto de la revista: FARMACOLOGIA / TOXICOLOGIA Año: 2016 Tipo del documento: Article

Buscar en Google

Imprimir

XML

PubMed Links